Five Prime Therapeutics Other Current Liabilities

Five Prime Therapeutics (FPRX) currently reports a other current liabilities of $19M as of December 2020. That compares with $19M in the prior-year period — down 0.4% year over year. Use the charts on this page to explore Five Prime Therapeutics's other current liabilities history and peer comparisons.

Five Prime Therapeutics's other current liabilities decreased from $19M to $19M — a 0.4% year-over-year decrease (period ending December 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Five Prime Therapeutics reported $19M in other current liabilities as of December 2020. That compares with $19M in the prior-year period — down 0.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $19M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Five Prime Therapeutics, and consider following FPRX for alerts when major investors trade the stock.

Five Prime Therapeutics is classified in the Healthcare sector. On other current liabilities, it currently shows $19M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FPRX with unrelated industries.